Diaceutics PLC (LON:DXRX) Insider Graham Paterson Purchases 11,643 Shares

Diaceutics PLC (LON:DXRX) insider Graham Paterson bought 11,643 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were bought at an average price of GBX 138 ($1.71) per share, for a total transaction of £16,067.34 ($19,912.43).

Diaceutics Stock Down 0.5 %

Shares of Diaceutics stock opened at GBX 136.25 ($1.69) on Friday. The firm has a market cap of £115.09 million, a PE ratio of -4,541.67 and a beta of 0.58. The business’s 50 day simple moving average is GBX 129.87 and its 200 day simple moving average is GBX 128.56. The company has a debt-to-equity ratio of 2.93, a quick ratio of 9.92 and a current ratio of 4.85. Diaceutics PLC has a 52-week low of GBX 92.24 ($1.14) and a 52-week high of GBX 151 ($1.87).

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on DXRX. Canaccord Genuity Group reissued a “buy” rating and set a GBX 160 ($1.98) price objective on shares of Diaceutics in a research report on Tuesday, December 17th. Canaccord Genuity Group reiterated a “buy” rating and set a GBX 160 ($1.98) target price on shares of Diaceutics in a report on Tuesday, December 17th.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.